This company listing is no longer active
Radius Health Balance Sheet Health
Financial Health criteria checks 2/6
Key information
-124.2%
Debt to equity ratio
US$339.57m
Debt
| Interest coverage ratio | n/a |
| Cash | US$72.49m |
| Equity | -US$273.40m |
| Total liabilities | US$427.84m |
| Total assets | US$154.44m |
Recent financial health updates
Recent updates
Radius stock rises as elacestrant gets FDA priority review to treat breast cancer subtype
Aug 11Reevaluating Radius Health
Feb 24Radius Health EPS misses by $0.02, misses on revenue
May 07When Will Radius Health, Inc. (NASDAQ:RDUS) Become Profitable?
Feb 23
Revisiting Radius Health
Feb 01Radius Health acquires global rights to RAD011 in Prader-Willi syndrome
Jan 06How Much Did Radius Health's(NASDAQ:RDUS) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 01
Radius Health on-track for record quarterly revenue for TYMLOS-SC
Dec 15Financial Position Analysis
Short Term Liabilities: RDUS has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: RDUS has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: RDUS has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: RDUS's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RDUS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: RDUS has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 23.4% each year.